Skip to main content

Advertisement

SpringerLink
Log in

Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain—a preliminary report

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Technetium-99m ethyl cysteinate dimer (Tc-99m ECD) brain single photon emission computed tomography (SPECT) was used to detect abnormal regional cerebral blood flow (rCBF) in 32 female patients with primary Sjögren's syndrome (PSS) showing definite neuropsychiatric symptoms/signs and normal brain magnetic resonance imaging (MRI) findings. It demonstrated hypoperfusion brain lesions in 18 (56.3%) of the patients, most frequently in the parietal lobes, and appears to be a sensitive tool for this clinical application.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Alexander E (1992) Central nervous system disease in Sjögren's syndrome: new insights into immunopathogenesis. Rheum Dis Clin North Am 18:637–672

    CAS  PubMed  Google Scholar 

  2. Farnam J, Jorizzo JL, Grant JA, Lavastida MT, Ichikawa Y, Daniels JC (1984) Sjögren's syndrome presenting with hypereosinophilia, lymphopenia and circulating immune complexes. Clin Exp Rheumatol 2:41–46

    Google Scholar 

  3. Fox RI, Howell FV, Bone RC, Michelson P (1984) Primary Sjögren's syndrome: clinical and immunopathological features. Semin Arthritis Rheum 14:77–105

    CAS  PubMed  Google Scholar 

  4. Sjögren H (1935) Zur Kenntnis der Keratoconjunctivitis Sicca II. Allgemeine Symptomatologie und Ätiologie. Acta Opthalmol (Kbh) 13:1–39

    Google Scholar 

  5. Hietaharju A, Yli-Kerttula U, Hakkinen V, Frey H (1990) Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand 81:144–152

    CAS  PubMed  Google Scholar 

  6. Alexander EL, Beall S, Provost TT (1989) Magnetic resonance imaging (MRI) in primary Sjögren's syndrome with central nervous system disease (CNS-SS): new clues to pathogenesis. Arthritis Rheum 29:S63

    Google Scholar 

  7. Manthorpe R, Manthorpe T, Sjoberg S (1992) Magnetic resonance imaging of the brain in patients with primary Sjögren's syndrome. Scand J Rheumatol 21:148–149

    CAS  PubMed  Google Scholar 

  8. Moutsopoulos HM, Sarmas JH, Talal N (1993) Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis Clin North Am 19:909–912

    CAS  PubMed  Google Scholar 

  9. Kao CH, Lan JL, ChangLai SP, Chieng PU (1998) Technetium-99m-HMPAO brain SPECT in Sjögren's syndrome. J Nucl Med 39:773–777

    CAS  PubMed  Google Scholar 

  10. Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volkert WA, Forster AM, Weisner PS, Marriott JA (1987) Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28:191–202

    Google Scholar 

  11. Juni JE, Waxman AD, Devous MD Sr, Tikofsky RS, Ichise M, Van Heertum RL, Holman BL, Carretta RF, Chen CC (1998) Procedure guideline for brain perfusion SPECT using technetium-99m radiopharmaceuticals. J Nucl Med 39:923–926

    CAS  PubMed  Google Scholar 

  12. Leveille J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC (1989) Characterization of Tc-99m-L,L-ECD for brain perfusion. Part 2. Biodistribution and brain imaging in humans. J Nucl Med 30:1902–1910

    CAS  PubMed  Google Scholar 

  13. Asenbaum S, Brucke T, Pirker W, Pietrzyk U, Podreka I (1998) Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. J Nucl Med 39:613–618

    CAS  PubMed  Google Scholar 

  14. Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H (1997) SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 38:587–592

    CAS  PubMed  Google Scholar 

  15. van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB (1996) Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. J Nucl Med 37:1749–1755

    CAS  PubMed  Google Scholar 

  16. Leveille J, Demonceau G, Walovitch RC (1992) Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 33:480–484

    CAS  PubMed  Google Scholar 

  17. Kuwabara Y, Ichiya Y, Otsuka M, Tahara T, Fukumura T, Gunasekera R, Masuda K (1990) Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging. Clin Nucl Med 15:893–899

    Google Scholar 

  18. DeVolder AG, Goffinet AM, Bol A, Michel C, de-Barsy T, Laterre C (1990) Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study. Arch Neurol 47:197–204

    CAS  PubMed  Google Scholar 

  19. Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenia purpura. Ann Neurol 23:380–384

    Google Scholar 

  20. Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994) Corticosteroid-responsive parkinsonism associated with primary Sjögren's syndrome. Clin Neurol Neurosurg 96:327–331

    CAS  PubMed  Google Scholar 

  21. Gerraty RP, McKelvie PA, Byrne E (1993) Aseptic meningoencephalitis in primary Sjögren's syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy. Acta Neurol Scand 88:309–311

    CAS  PubMed  Google Scholar 

  22. Berman JL, Kashii S, Trachtman MS, Burde RM (1990) Optic neuropathy and central nervous system disease secondary to Sjögren's syndrome in a child. Ophthalmology 97:1606–1609

    CAS  PubMed  Google Scholar 

  23. de la Monte SM, Hutchins GM, Gupta PK (1983) Polymorphous meningitis with atypical mononuclear cells in Sjögren's syndrome. Ann Neurol 14:455–461

    Google Scholar 

  24. Alexander EL, Provost TT, Stevens MB, Alexander GE (1982) Neurologic complications of primary Sjögren's syndrome. Medicine 61:247–257

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, China Medical College Hospital, Taichung, Taiwan

    W. S. Huang, P. Y. Chiu & C. H. Tsai

  2. Departments of Nuclear Medicine and Medical Research, China Medical College Hospital, No. 2 Yuh-Der Road, Taichung 404, Taiwan

    A. Kao & C. C. Lee

Authors
  1. W. S. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Y. Chiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Kao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. H. Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. C. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Kao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, W.S., Chiu, P.Y., Kao, A. et al. Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain—a preliminary report. Rheumatol Int 23, 174–177 (2003). https://doi.org/10.1007/s00296-002-0272-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-002-0272-1

Keywords

Search

Navigation